Biochanin A Sensitizes Glioblastoma to Temozolomide by Inhibiting Autophagy
Sign Up to like & getrecommendations! Published in 2022 at "Molecular Neurobiology"
DOI: 10.1007/s12035-021-02674-6
Abstract: Resistance to temozolomide (TMZ) chemotherapy is the main reason for treatment failure in patients with glioblastoma (GBM). In the present study, we investigated biochanin A (BCA) a potent sensitizer of TMZ in GBM. We observed… read more here.
Keywords: temozolomide inhibiting; glioblastoma temozolomide; inhibiting autophagy; sensitizes glioblastoma ... See more keywords